Dr. Marcos Restrepo, Pulmonary Diseases, explains new research about a novel concept called “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.
Newsroom
Dr. Marcos Restrepo, Pulmonary Diseases, explains new research about a novel concept called “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.